Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

BBNXBBNX
6 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in BETA BIONICS INC

Yes. Northern Trust holds 331,956 shares of BBNX (Beta Bionics), worth $5.2M, as of its Q2 2026 13F filing. It increased the position by 36,138 shares (+12.2%) from Q1 2026. Northern Trust has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$5.2M

Current Shares

331,956

Total Value Change

+$3.8M

Total Shares Change

+220,469

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
331,956
+12.2%
$5.2M0.0%$15.67
30
2026-Q1
Increased
295,818
+4.0%
$3M0.0%$11.57
27
2025-Q4
Decreased
284,453
-4.6%
$8.7M0.0%$31.97
0
2025-Q3
Increased
298,060
+212.9%
$5.9M0.0%$19.85
44
2025-Q2
Decreased
95,253
-14.6%
$1.4M0.0%$15.07
0
2025-Q1
New
111,487
-
$1.4M0.0%$11.71
35

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used